Navigation Links
Gene may hold key to future cancer hope
Date:10/8/2007

Scientists may have discovered a new way of killing tumours in what they hope could one day lead to alternative forms of cancer treatments.

The University of Manchester research has identified a key gene that appears to play a critical role in the normal process of cell division.

Cells divide creating new cells as part of the bodys natural growth, renewal and healing processes but cancer results when cells divide in an uncontrolled way.

What the Manchester team has discovered is that a protein in our cells called Bub 1 is essential for normal cell division to take place; if the gene that generates Bub 1 is switched off then the cells are unable to divide successfully.

Bub 1 is an enzyme that controls several processes required for cell division to occur, said Dr Stephen Taylor, who led the research in the Faculty of Life Sciences.

We have shown that mouse embryos lacking the Bub 1 gene are unable to develop. Older cell types also failed to divide when the gene is switched off, while male mice lacking Bub 1 became infertile as their sperm cells died.

In fact, deactivating Bub 1 had such a profound effect on cell division at all stages of a cells life - known as the cell cycle - that the team is hopeful it will have a similar effect on cancer cells.

Before cells can divide they have to duplicate and then distribute their genetic material so that the two daughter cells receive all the genetic information for further growth and development, said Dr Taylor, whose work is funded by the charity Cancer Research UK.

The distribution phase has to be done with a high degree of accuracy - just one chromosome segregated incorrectly, for instance, leads to Downs syndrome - so the cell has a surveillance mechanism which acts as a brake to delay chromosome segregation until accuracy has been guaranteed.

An important part of this intricate surveillance system is Bub 1. The team found that when the gene is switched off the surveillance mechanism fails and accuracy is lost, resulting in cell death.

Now that scientists understand the precise role of Bub 1 in normal cell division, as well as what goes wrong when the gene is missing, they plan to test their theory on cancer cells.

Unlike some other genes that become mutated in cancer cells, the Bub 1 gene appears normal indicating that it behaves in exactly the same way in cancer cells as it does in healthy cells.

If this is the case, then we can be confident that switching it off will stop cancer cells proliferating too. And while our normal cells dont divide that often, cancer cells divide more frequently, so hopefully by targeting Bub1 we will selectively kill cancer cells.

Equally exciting, says Dr Taylor, is the fact that drugs are already being developed that are able to block the actions of Bub 1-type enzymes, known as protein kinases; such kinase blockers or inhibitors are already providing a whole new approach to tackling cancer and Bub1 inhibitors may be another weapon in the oncologist's arsenal.

The research, which began in 1999, is published in the journal Developmental Cell on Tuesday, October 9.


'/>"/>
Contact: Aeron Haworth
aeron.haworth@hotmail.com
44-161-275-8383
University of Manchester
Source:Eurekalert

Related biology news :

1. HIV vaccine trial breaks ground for future research
2. Future diabetes drugs may target new protein interaction
3. Prozac for future Plants on Mars
4. Purdues gold nanorods brighten future for medical imaging
5. Plants reveal a secret and bring researchers nearer a cleaner future
6. Report focuses on challenges to unlocking future promise of vaccines
7. Researchers make long DNA wires for future medical and electronic devices
8. New U. of Colorado at Boulder flu chip may help combat future epidemics, pandemics
9. Understanding the oceans microbes is key to the Earths future
10. Tastier tomatoes in the future?
11. Stable polymer nanotubes may have a biotech future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software as ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video ... trial team. , Using the CONSULT module, patients and physicians can schedule a face ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
Breaking Biology Technology: